TRPV6 and cancer: A limited number of small-molecule23–26 and peptide27 inhibitors of TRPV6 have been identified as potential leads for cancer treatment, but advances in drug development are hampered by lack of knowledge about the possible molecular mechanisms of TRPV6 inhibition.